FTC releases interim staff report on prescription drug middlemenThe interim staff report details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States. Babson Diagnostics unveils BetterWay blood testing across AustinBabson Diagnostics' BetterWay brings blood testing services to retail pharmacies. FDA approves Arcutis’ Zoryve for the treatment of atopic dermatitis Adults and children 6 years or older are approved to use the cream. FDA approves 2 Eylea biosimilars Yesafili and Opuviz are interchangeable biosimilars to Regeneron's Eylea. Alembic intros generic Oracea Doxycycline monohydrate is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adult patients. NCPA kicks off new TV ad: "PBM Career Day" The new ad is part of NCPA's campaign to push lawmakers to enact pharmacy benefit manager reform. Watch DSN: Walgreens expands role in clinical trials for greater healthcare access DSN senior reporter Sandra Levy visited Perth Amboy, N.J., to discuss the new initiative with the retailer's clinical trials team. Albertsons taps Soda Health to bring Medicare Advantage benefits online Due to a partnership with Soda Health, Medicare Advantage coverage is now usable online at Albertsons.com. CeraVe rallies dermatologists nationwide to volunteer time on World Skin Health Day The brand is joining the International League of Dermatological Societies and the International Society of Dermatology to spread skin health awareness in underserved communities on July 8. Dr Reddy's, Zydus Lifesciences to co-market Pertuzumab biosimilar in India Zydus will market the product under the brand name Sigrima, while Dr. Reddy's will market it as Womab. First Previous 25 26 27 28 29 Next Last
